nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Lisinopril—ACE—focal segmental glomerulosclerosis	0.11	1	CrCbGaD
Lisdexamfetamine—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0616	0.0692	CcSEcCtD
Lisdexamfetamine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0322	0.0362	CcSEcCtD
Lisdexamfetamine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0316	0.0355	CcSEcCtD
Lisdexamfetamine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0297	0.0333	CcSEcCtD
Lisdexamfetamine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.0294	0.0331	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0273	0.0307	CcSEcCtD
Lisdexamfetamine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.0235	0.0264	CcSEcCtD
Lisdexamfetamine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0234	0.0263	CcSEcCtD
Lisdexamfetamine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.023	0.0258	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0227	0.0255	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0226	0.0254	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0218	0.0245	CcSEcCtD
Lisdexamfetamine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0207	0.0232	CcSEcCtD
Lisdexamfetamine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0199	0.0224	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0186	0.0209	CcSEcCtD
Lisdexamfetamine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0181	0.0204	CcSEcCtD
Lisdexamfetamine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.018	0.0202	CcSEcCtD
Lisdexamfetamine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.0175	0.0197	CcSEcCtD
Lisdexamfetamine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0191	CcSEcCtD
Lisdexamfetamine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.019	CcSEcCtD
Lisdexamfetamine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0186	CcSEcCtD
Lisdexamfetamine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0185	CcSEcCtD
Lisdexamfetamine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0175	CcSEcCtD
Lisdexamfetamine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0175	CcSEcCtD
Lisdexamfetamine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0172	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0171	CcSEcCtD
Lisdexamfetamine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0168	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0165	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0162	CcSEcCtD
Lisdexamfetamine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.016	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.016	CcSEcCtD
Lisdexamfetamine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.014	0.0157	CcSEcCtD
Lisdexamfetamine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.0133	0.0149	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0147	CcSEcCtD
Lisdexamfetamine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0147	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0145	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0144	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0143	CcSEcCtD
Lisdexamfetamine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0142	CcSEcCtD
Lisdexamfetamine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0141	CcSEcCtD
Lisdexamfetamine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0131	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0131	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0122	CcSEcCtD
Lisdexamfetamine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0118	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0113	CcSEcCtD
Lisdexamfetamine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00972	0.0109	CcSEcCtD
Lisdexamfetamine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00934	0.0105	CcSEcCtD
Lisdexamfetamine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00927	0.0104	CcSEcCtD
Lisdexamfetamine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00926	0.0104	CcSEcCtD
Lisdexamfetamine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00921	0.0103	CcSEcCtD
Lisdexamfetamine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00873	0.00981	CcSEcCtD
